Health Canada sticks with Evusheld despite U.S. FDA dropping the COVID drug
While Health Canada says it is "aware" of the U.S. decision to withdraw the emergency use of Evusheld, a drug by AstraZeneca used to help prevent COVID-19 infection--- the agency is maintaining its approval, citing the differences in variant circulation between Canada and the U.S.
The U.S. Food and Drug Administration (FDA) announced on Jan. 26 that its emergency use authorization of the drug was pulled due to its inefficacy in treating “certain” COVID-19 variants.
The FDA stated in a release on its website that as the XBB.1.5. variant, nicknamed “Kraken”, is making up the majority of cases in the country, the use of Evusheld is “not expected to provide protection” and therefore not worth exposing the public to possible side effects of the drug, like allergic reactions.
In an email to CTVNews.ca, Health Canada said the U.S. Food and Drug Administration pulled the drug as the main variant of concern in the U.S. is XBB.1.5.
"Dominant variants in the [U.S.] may be different from those circulating in Canada," the federal agency said in an email. "The most recent epidemiological data in Canada (as of January 1, 2023) indicate that BA.5 (Omicron) subvariants continue to account for more than 89 per cent of reported cases."
On Jan. 6 the FDA said in press release that certain variants are not neutralized by Evusheld and cautioned people who are exposed to XBB.1.5. On Jan. 26, the FDA then updated its website by saying it would be limiting the use of Evusheld.
"Evusheld is not currently authorized for use in the U.S. until further notice by the Agency," the FDA website states.
On Jan. 17, Health Canada issued a "risk communication" on Evusheld, explaining how it may not be effective against certain Omicron subvariants when used as a preventative measure or treatment for COVID-19.
"Decisions regarding the use of EVUSHELD should take into consideration what is known about the characteristics of the circulating COVID-19 variants, including geographical prevalence and individual exposure," Health Canada said in an email.
Health Canada says Evusheld does neutralize against Omicron subvariant BA.2, which according to the agency, is the dominant variant in many communities in Canada.
The drug was introduced for prevention measures specifically for people who have weaker immune systems and are unlikely to be protected by a COVID-19 vaccine. It can only be given to people 12 years and older.
"EVUSHELD is not a substitute for vaccination in individuals for whom COVID-19 vaccination is recommended," the agency's website reads.
Health Canada says no drug, including Evusheld, is a substitute for vaccination.
COVID-19 COVERAGE
CTVNews.ca Top Stories
BREAKING | Ottawa gives final approval for Rogers $26B purchase of Shaw
Rogers Communications Inc's $26-billion takeover of Shaw Communications Inc. cleared the last regulatory hurdle Friday, more than two years after the deal was first announced.

Donald Trump indicted; 1st ex-president charged with crime
Donald Trump has been indicted by a Manhattan grand jury, prosecutors and defense lawyers said Thursday, making him the first former U.S. president to face a criminal charge and jolting his bid to retake the White House next year.
Police find 6 bodies, including 1 child, in St. Lawrence River
The bodies of six people, including one child, were found in the St. Lawrence River Thursday afternoon after an air search involving the Canadian Coast Guard, the Akwesasne Mohawk Police said.
These are the conditions -- and penalties if violated -- of the Rogers-Shaw deal
Canadian Industry Minister François-Philippe Champagne has approved Rogers Communications Inc.'s $20-billion takeover of rival telecom Shaw Communications Inc., but there are conditions attached and penalties of up to $1 billion if the companies violate them.
BREAKING | Oscar Pistorius denied parole as Reeva Steenkamp's parents oppose his early release
Disgraced South African Paralympic sprinter Oscar Pistorius has been denied parole, the lawyer for Reeva Steenkamp's parents said after the parole hearing.
Syphilis cases in babies skyrocket in Canada amid health-care failures
The numbers of babies born with syphilis in Canada are rising at a far faster rate than recorded in the United States or Europe, an increase public health experts said is driven by increased methamphetamine use and lack of access to the public health system for Indigenous people.
House abandoned by couple who 'disappeared' years ago nightmare for neighbour on upscale street
A Toronto man, whose neighbours vanished eight years ago and left their home completely abandoned, said he's fed up living next door to a property that is in complete disarray.
Former Conservative leader Erin O'Toole not seeking re-election, leaving this spring
Former Conservative leader Erin O'Toole says he will not seek re-election and plans to resign his seat this spring. The Ontario MP led the Conservatives and served as official Opposition leader from August 2020 until February 2022, when a majority of his caucus voted to remove him from the post.
Trump's indictment in New York: Here's what to know
The vote of a Manhattan grand jury to indict the Republican former president on charges related to hush money payments made on his behalf during his 2016 presidential campaign catapults the now-candidate Donald Trump into a new era of legal risk and complicates his attempts to return to the White House.